Search Results - "MALAMOS, N. A"

Refine Results
  1. 1

    Weekly administration of topotecan-paclitaxel as second-line treatment in ovarian cancer by STATHOPOULOS, G. P, MALAMOS, N. A, ARAVANTINOS, G, RIGATOS, S, CHRISTODOULOU, Ch, STATHOPOULOS, J, SKARLOS, D

    Published in Cancer chemotherapy and pharmacology (01-06-2007)
    “…To investigate the weekly administration of topotecan combined with paclitaxel in pretreated advanced ovarian cancer patients; our objectives were to determine…”
    Get full text
    Journal Article
  2. 2

    Irinotecan combined with docetaxel in pre-treated metastatic breast cancer patients : a phase II study by STATHOPOULOS, G. P, TSAVDARIDIS, D, MALAMOS, N. A, RIGATOS, S. K, KOSMAS, Ch, PERGANTAS, N, STATHOPOULOS, J. G, XYNOTROULAS, J

    Published in Cancer chemotherapy and pharmacology (01-11-2005)
    “…This is a phase II study where a novel chemotherapy combination was tested in pre-treated breast cancer patients: docetaxel and irinotecan have already been…”
    Get full text
    Journal Article
  3. 3

    Phase II Study of Paclitaxel, Ifosfamide, and Cisplatin as Second-Line Treatment in Relapsed Small-Cell Lung Cancer by KOSMAS, Christos, TSAVARIS, Nicolas B, MALAMOS, Nikolaos A, VADIAKA, Maria, KOUFOS, Christos

    Published in Journal of clinical oncology (01-01-2001)
    “…The aim of the present phase II study was to evaluate the efficacy of the paclitaxel, ifosfamide, and cisplatin (PIC) combination in relapsed small-cell lung…”
    Get full text
    Journal Article
  4. 4

    Phase I study of dose-escalated paclitaxel, ifosfamide, and cisplatin (PIC) combination chemotherapy in advanced solid tumours by KOSMAS, C, TSAVARIS, N. B, POLYZOS, A, MALAMOS, N. A, KATSIKAS, M, ANTONOPOULOS, M. J

    Published in British journal of cancer (01-01-2000)
    “…Based on the already known in vitro synergy between paclitaxel (taxol), cisplatin and oxazophosphorine cytostatics and the broad spectrum of activity of the…”
    Get full text
    Journal Article
  5. 5

    Paclitaxel combined with cis-platin as second-line treatment in patients with advanced non-small cell lung cancers refractory to cis-platin by Stathopoulos, G P, Rigatos, S, Malamos, N A

    Published in Oncology reports (01-07-1999)
    “…We combined paclitaxel with cis-platin as second-line treatment in patients with non-small cell lung cancer (NSCLC) who had previously undergone first-line…”
    Get more information
    Journal Article
  6. 6

    Chemotherapy-induced complete regression of choroidal metastases and subsequent isolated leptomeningeal carcinomatosis in advanced breast cancer : a case report and literature review by KOSMAS, C, MALAMOS, N. A, TSAVARIS, N, ANTONOPOULOS, M

    Published in Journal of neuro-oncology (01-04-2000)
    “…Choroidal metastases from breast cancer represent an unusual metastatic presentation that has been traditionally treated with radiation therapy. Herein, we…”
    Get full text
    Journal Article
  7. 7

    Intramedullary Spinal Cord Metastases in Breast Carcinoma: Report of Two Cases and Review of the Literature by Kosmas, C., Malamos, N.A., Stefanou, S., Gregoriou, A., Tsavaris, N.

    Published in Journal of chemotherapy (Florence) (01-12-2002)
    “…Intramedullary spinal cord metastases (ISCM) are usually the result of rapidly progressing systemic malignancy. Breast cancer is one of the most common solid…”
    Get full text
    Journal Article
  8. 8

    Pregnancy and offspring after the appearance of breast cancer by Malamos, N A, Stathopoulos, G P, Keramopoulos, A, Papadiamantis, J, Vassilaros, S

    Published in Oncology (01-11-1996)
    “…The objective of this study was to investigate the influence of pregnancy in breast cancer prognosis of women under the age of 35 years. Two hundred and…”
    Get more information
    Journal Article
  9. 9

    A Phase II study of paclitaxel‐ifosfamide‐cisplatin combination in advanced nonsmall cell lung carcinoma by Kosmas, Christos, Tsavaris, Nicolas B., Polyzos, Aristidis, Kalofonos, Haralambos P., Sepsas, Evangelos, Malamos, Nikolaos A., Vadiaka, Maria, Dosios, Theodosios, Antonopoulos, Minas J.

    Published in Cancer (15-08-2000)
    “…BACKGROUND The necessity to develop more effective chemotherapy regimens in advanced nonsmall cell lung carcinoma (NSCLC) prompted the authors to evaluate the…”
    Get full text
    Journal Article
  10. 10

    Inhibition of adriamycin cardiotoxicity by 5-fluorouracil: a potential free oxygen radical scavenger by Stathopoulos, G P, Malamos, N A, Dontas, I, Deliconstantinos, G, Perrea-Kotsareli, D, Karayannacos, P E

    Published in Anticancer research (01-11-1998)
    “…Adriamycin (ADR), a broad spectrum anticancer agent, has a limit to total dose used, due to cumulative cardiotoxicity. This side effect has been tested in the…”
    Get more information
    Journal Article
  11. 11

    Induction chemotherapy in non small cell lung cancer stage IIIa-b and IV and second-line treatment by Stathopoulos, G P, Dafni, U G, Malamos, N A, Rigatos, S, Kouvatseas, G, Moschopoulos, N

    Published in Anticancer research (01-07-1999)
    “…This study investigates the treatment management and survival of inoperable advanced non-small cell lung cancer (NSCLC) patients. The objective was to treat…”
    Get more information
    Journal Article
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16

    Vena Caval Obstruction by Tumor by Luckey, R C

    Published in The New England journal of medicine (24-02-1994)
    “…To the Editor: In the September 30 issue the Image in Clinical Medicine 1 was alleged to be that of the superior vena cava syndrome. It showed the torso of a…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19

    Treatment of Intermediate-Grade and High-Grade Non-Hodgkin's Lymphoma by Wirth, A, Prince, H M, Wolf, M

    Published in The New England journal of medicine (12-11-1998)
    “…To the Editor: Miller et al. (July 2 issue) 1 are to be commended on their report of the randomized trial comparing full-dose chemotherapy with limited…”
    Get full text
    Journal Article
  20. 20

    Weekly administration of topotecan and paclitaxel in pretreated advanced cancer patients: a phase I/II study by STATHOPOULOS, George P, RIGATOS, Sotiris K, CHRISTODOULOU, Christos, MALAMOS, Nikos A, DELIYIANNIS, Filippos, STATHOPOULOS, John G, SKARLOS, Dimosthenis V

    Published in Cancer chemotherapy and pharmacology (01-09-2004)
    “…This study was a phase I/II, cohort, dose-escalation trial of topotecan and paclitaxel. Its aim was to determine the dose-limiting toxicity (DLT) of the…”
    Get full text
    Journal Article